Press Release

Date: July 21, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited (NSE) BSE Limited (BSE) Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/1, G-Block Dalal Street Bandra-Kurla Complex Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code:544282 Symbol: SAGILITY Dear Sir/Ma’am, Sub: Press Release pertaining to the Unaudited Financial Results for the quarter ended June 30, 2026. With reference to the captioned subject, please find enclosed the press release issued by Sagility Limited pertaining to the unaudited financial results for the quarter ended June 30, 2026. This is for your information and record. Thanking You, For Sagility Limited Satishkumar Sakharayapattana Seetharamaiah Company Secretary & Compliance Officer M. No. A16008 Encl: a/a Sagility Limited (Formerly Sagility India Limited, earlier Sagility India Private Limited) Registered Office - No. 23 & 24, AMR Tech Park, Building 2A, First Floor Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru – 560068, Karnataka, India Corporate Identification Number: L72900KA2021PLC150054 Tel. No.: 080-71251500, E-mail: investorservices@sagility.com, Website: www.sagility.com Sagility Ltd. Press Release Performance Review of Q1 FY27 Strong Q1 performance with Revenue growth of 27.6% YoY (15.2% in constant currency) Adjusted EBITDA at 24.0% with 27.9% growth YoY Adjusted PAT at 13.7% with 35.1% growth YoY Bengaluru, India | Jul 21, 2026: Sagility Limited (NSE: SAGILITY, BSE: 544282), a leading global healthcare operations partner that helps U.S. payers, providers, and pharmacy benefit managers reduce costs, improve quality, and enhance member and provider experiences, reported its consolidated financial results for the quarter Q1 FY27 ended June 30, 2026, according to IndAS. Financial highlights for the quarter ended Jun 30, 2026: • Revenue at INR 19,635 million (US$ 207.8 million), YoY growth of 27.6% (15.2% in CC terms) • Organic YoY growth of 27.3% (14.9% in CC terms) • Reported revenue softened QoQ due to Q4 OE/AEP seasonality, excluding which steady-state organic revenue grew 5.1% QoQ in CC terms, with recurring seasonal revenues slated to return in Q3 & Q4 FY27 • Adjusted EBITDA at INR 4,716 million (US$ 49.9 million) at 24.0% of revenue, YoY growth of 27.9% • Adjusted PAT at INR 2,697 million (US$ 28.6 million) at 13.7% of revenue, YoY growth of 35.1% • Basic Earnings per share (EPS) at INR 0.46, YoY growth of 45.9% • Adjusted Basic Earnings per share (EPS) at INR 0.58, YoY growth of 35.1% Business Highlights: • Sagility secured $35.3 million of steady-state ACV driven by expansion within existing clients and rising contribution from FY26 new client wins. • Added 27 clients in Q1 FY27 (including CareSeed); increasing the total client base to 109 • Acquired CareSeed to strengthen our position in healthcare quality, especially for Medicare Advantage plans, thereby adding differentiated analytics and HEDIS capabilities while expanding our platform depth and mid-market reach. Added 26 new clients via CareSeed acquisition • Employees: At the end of Q1, Sagility had 47,307 employees • Geo Presence: As of June 30, 2026, Sagility had a presence in 5 countries with 29 delivery centers Rewards & Recognitions: • Sagility is recognized as Major Contender – Healthcare Customer Experience Management (CXM) Intelligent Operations PEAK Matrix® Assessment 2026 • Sagility is recognized as Major Contender – Revenue Cycle Management (RCM) Intelligent Operations PEAK Matrix® Assessment 2026 • Sagility is recognized as Leader in – Avasant Clinical and Care Management Business Process Transformation 2026 RadarViewTM • Sagility India has been ranked 11th among India’s 100 Best Companies to Work For 2026 by Great Place to Work® India • Recognized by ET Edge as Best Organizations for Women Sagility Ltd. Press Release Commenting on the results announcement, Ramesh Gopalan, Managing Director and Group CEO said, “Healthcare organizations are increasingly looking for partners that can combine healthcare expertise with technology, AI, and operational accountability to deliver measurable outcomes. We are seeing growing demand for outcome-oriented managed services engagements, and the early momentum behind Sagility Synchrony reinforces our belief that the future of healthcare operations lies in more integrated, intelligent operating models. Our acquisition of CareSeed further strengthens our capabilities in healthcare quality and expands our reach in the Medicare Advantage and mid-market segments.” Srinivas Mattapalli, Group Chief Financial Officer added, "We have started the year on a strong note, supported by healthy business momentum, resilient profitability and robust cash generation. Our performance reflects the strength of Sagility’s healthcare-focused model, the depth of our client relationships and our strong execution across markets. With a strong balance sheet, healthy cash flows and clear strategic priorities, we remain well placed to invest in growth, strengthen our capabilities and drive sustainable long-term value for our stakeholders.” About Sagility Limited Sagility is a leading healthcare operations partner that helps payers, providers, and pharmacy benefit managers reduce costs, improve quality, and enhance member and provider experiences. With more than 25 years of exclusive focus in healthcare, Sagility combines deep domain expertise with technology-led transformation - embedding analytics, automation, and AI directly into operations while ensuring compliance with complex regulatory and clinical requirements. Serving over 100 healthcare clients, including 7 of the top U.S. health plans, Sagility delivers end-to-end operational transformation at scale through a model built on accountability, transparency, and measurable outcomes. To learn more, visit: https://sagility.com/ Safe Harbour Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actual results to differ materially from such statements. The Company does not undertake to update any forward-looking statement that may be made from time to time, except as required by applicable law. Contact Investor Relations Abhishek Kayan abhishek.kayan@sagility.com Sagility Ltd. Press Release KPIs TTM TTM Quarter KPIs Q1 FY27 Q4 FY26 Q1 FY26 Y-o-Y % Y-o-Y% Jun26 Jun25 Revenue from Operations (in INR million) 19,635 20,243 15,389 27.6% 76,174 58,855 29.4% Steady state revenue 19,635 17,983 15,389 27.6% 71,647 57,154 25.4% Seasonal revenue (OE / AEP) - 2,260 - 4,527 1,701 166.2% Revenue by Vertical split By Payer (in INR million) 17,585 18,388 13,597 29.3% 68,475 52,473 30.5% By Provider (in INR million) 2,050 1,855 1,792 14.4% 7,699 6,382 20.6% Growth in revenue from operations (%) 27.6% 29.1% 25.8% 29.4% 21.1% Reported EBITDA (in INR million) 4,525 5,094 3,560 27.1% 19,548 14,918 31.0% Reported EBITDA % 23.0% 25.2% 23.1% 25.7% 25.3% Profit/ (Loss) before tax (in INR million) 2,875 3,632 2,104 36.6% 13,160 8,996 46.3% Profit/ (Loss) before tax margin % 14.6% 17.9% 13.7% 17.3% 15.3% Profit/ (Loss) after tax (in INR million) 2,168 2,577 1,486 45.9% 9,930 6,654 49.2% Profit/ (Loss) after tax margin % 11.0% 12.7% 9.7% 13.0% 11.3% Adjusted EBITDA (in INR million) * 4,716 5,036 3,687 27.9% 19,228 15,456 24.4% Adjusted EBITDA % 24.0% 24.9% 24.0% 25.2% 26.3% Adjusted PAT (in INR million) ** 2,697 3,069 1,997 35.1% 12,006 8,657 38.7% Adjusted PAT % 13.7% 15.2% 13.0% 15.8% 14.7% Total Number of Employees 47,307 46,860 39,917 18.5% 47,307 39,917 18.5% Voluntary attrition rate *** 28.6% 38.1% 27.6% 30.5% 27.5% *Adjusted EBITDA represents EBITDA adjusted for earnouts payable under acquisition agreements (DCI, BirchAI, BroadPath & CareSeed), share-based payment awards and excludes other income (including forex gain/loss). **Adjusted PAT reflects EBITDA adjustments and [Showing first 8,000 characters — download PDF for full document]